John Goodman’s Commentaries
Why Are There Drug Shortages?
For the past two decades the US has been experiencing shortages of cancer drugs, antibiotics and even saline, a drug potentially needed by almost every patient who gets admitted to the hospital. Nearly all thirty of the most frequently used emergency department drugs experienced shortages from 2006-2019.
Social Security and Medicare Reform
How Much Do We Owe?
What Congressional Republicans are Getting Wrong
When John F. Kennedy won the presidency in 1960, he won the majority of white voters who didn’t have a college degree. But he lost white college graduates by a two-to-one margin. The numbers were almost exactly reversed for Joe Biden.
Why Are Politicians Ignoring the Elderly
According to Federal Reserve chief Jerome Powell, 3.5 million workers have permanently departed from the workforce. Of that number, 2 million have retired. Can’t retirees change their mind, and at least take a part-time job? In principle, yes. But the federal government does its mighty best to discourage them from doing that. More
Health Care in the Senate Next Year
The committee chair will be Bernie Sanders and Bill Cassidy will be the ranking member. Ironically, both believe in universal coverage that could be achieved with no increase in health care spending. Sanders will need help from Cassidy if anything is to be done in a closely divided Senate. The problem: their visions for health care are so different, there is almost no overlap. More.
What Can We Learn from the Election?
Why Do Progressives Support Democrats? Part II
Why Do Progressives Support Democrats? Part I
The words “progressive” and “Democrat” have become virtually synonymous in modern parlance. But did you know that the most important progressive reform ideas of the last half-century have not come from the left? They have come from Republican politicians and right-of-center intellectuals and think tanks. More.
Hidden Traps in the IRA Bill’s Drug Provisions
In the near future, the elderly and the disabled will face a double whammy: higher premiums for Part D drug insurance and higher prices at the pharmacy. This is on top of negotiated prices (and the consequent drop in new drug production) which will kick in later in the decade.
John Goodman and Linda Gorman explain why this will happen in The Hill.